Moreover, in silico data analyses revealed that, for some cancers, such as pancreatic, lung, stomach or rectum adenocarcinomas, patients with tumors displaying little or no CDA expression have a better prognosis [21] (Fig. 5). This evidence concerns the gene CDA and digestive system cancer.